| __timestamp | Dr. Reddy's Laboratories Limited | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 132170000000 | 122045000 |
| Thursday, January 1, 2015 | 148189000000 | 144427000 |
| Friday, January 1, 2016 | 154708000000 | 215003000 |
| Sunday, January 1, 2017 | 140809000000 | 302238000 |
| Monday, January 1, 2018 | 142028000000 | 408897000 |
| Tuesday, January 1, 2019 | 153851000000 | 392755000 |
| Wednesday, January 1, 2020 | 174600000000 | 520397000 |
| Friday, January 1, 2021 | 189722000000 | 579775000 |
| Saturday, January 1, 2022 | 214391000000 | 667238000 |
| Sunday, January 1, 2023 | 245879000000 | 607521000 |
| Monday, January 1, 2024 | 279164000000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, revenue generation is a key indicator of success. Dr. Reddy's Laboratories Limited, a global player, has consistently outperformed Supernus Pharmaceuticals, Inc., a U.S.-based company, in terms of annual revenue. From 2014 to 2023, Dr. Reddy's revenue surged by approximately 111%, peaking at an impressive 279 billion in 2024. In contrast, Supernus Pharmaceuticals experienced a more modest growth of around 398% over the same period, reaching a maximum of 667 million in 2022. This stark difference highlights Dr. Reddy's dominant market position, driven by its expansive product portfolio and global reach. However, Supernus's growth trajectory, despite being on a smaller scale, reflects its strategic focus on niche markets. The data for 2024 is incomplete for Supernus, indicating potential future insights yet to be uncovered.
Breaking Down Revenue Trends: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Novartis AG and Dr. Reddy's Laboratories Limited: A Comprehensive Revenue Analysis
Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down Revenue Trends: BeiGene, Ltd. vs Dr. Reddy's Laboratories Limited
Comparing Revenue Performance: Dr. Reddy's Laboratories Limited or Cytokinetics, Incorporated?
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc. Allocate Funds
Revenue Insights: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Ligand Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Supernus Pharmaceuticals, Inc. and Dynavax Technologies Corporation Performance Compared
Revenue Insights: Supernus Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared